Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

Helmut Albrecht(Prisma Health), Hans-Jürgen Stellbrink(Universität Hamburg), Olaf Degen(Universität Hamburg), Christian Eggers(Johannes Kepler University of Linz), T. Mertenskötter(Bernhard Nocht Institute for Tropical Medicine), Albrecht Stoehr, Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Andreas Plettenberg(Institute for Interdisciplinary Medicine)
AIDS
July 1, 1998
10.1097/00002030-199810000-00006
Cited by 151

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
|Journal of Neurology|2017|336